Progress and challenges in translating the biology of atherosclerosis

Inflammation, Atherosclerosis, and Coronary Artery Disease

Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773

Effects of Intensive Glucose Lowering in Type 2 Diabetes

(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674

Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes

Cannon, C. P., Braunwald, E., McCabe, C. H., Rader, D. J., Rouleau, J. L., Belder, R., Joyal, S. V., Hill, K. A., Pfeffer, M. A., & Skene, A. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040583 · Cited by 4,938

Atherosclerosis

Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,880

Glucose control and vascular complications in veterans with type 2 diabetes

Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026

Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia

Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881 · cited 1×

Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein

Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J. J., Gotto, A. M., Kastelein, J. J. P., Köenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641

Mergeomics: multidimensional data integration to identify pathogenic perturbations to biological systems

Shu, L., Zhao, Y., Kurt, Z., Byars, S., Tukiainen, T., Kettunen, J., Orozco, L. D., Pellegrini, M. A., Lusis, A. J., Ripatti, S., et al. (2016) · BMC Genomics · doi:10.1186/s12864-016-3198-9 · Cited by 132

Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis

Dou, Y., Chen, Y., Zhang, X., Xu, X., Chen, Y., Guo, J., Zhang, D., Wang, R., Li, X., & Zhang, J. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.07.035 · Cited by 133

Clonally expanding smooth muscle cells promote atherosclerosis by escaping efferocytosis and activating the complement cascade

Wang, Y., Nanda, V., Direnzo, D., Ye, J.-Q., Xiao, S., Kojima, Y., Howe, K., Jarr, K., Flores, A. M., Tsantilas, P., et al. (2020) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.2006348117 · Cited by 116

Lycopene: A Natural Arsenal in the War against Oxidative Stress and Cardiovascular Diseases

Bin-Jumah, M. N., Nadeem, M. S., Gilani, S. J., Mubeen, B., Ullah, I., Alzarea, S. I., Ghoneim, M. M., Alshehri, S., Al-Abbasi, F. A., & Kazmi, I. A. (2022) · Antioxidants · doi:10.3390/antiox11020232 · Cited by 148

Biomimetic cell membrane‐coated poly(lactic‐ co ‐glycolic acid) nanoparticles for biomedical applications

Jan, N., Madni, A., Khan, S., Shah, H., Akram, F., Khan, A., Ertas, D., Bostanudin, M. F., Contag, C. H., Ashammakhi, N. A., et al. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10441 · Cited by 133

Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues

Sherratt, S. C. R., Libby, P., Budoff, M. J., Bhatt, D. L., & Mason, R. P. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-01075-x · Cited by 156

Endothelial Function and Dysfunction: Impact of Metformin

Nafisa, A., Gray, S. G., Cao, Y., Wang, T., Xu, S., Wattoo, F. H., Barras, M., Cohen, N., Kamato, D., & Little, P. J. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.07.007 · Cited by 128

Painting blood vessels and atherosclerotic plaques with an adhesive drug depot

Kastrup, C. J., Nahrendorf, M., de Figueiredo, J. L., Lee, H., Kambhampati, S., Lee, T. J., Cho, S., Gorbatov, R., Iwamoto, Y., Dang, T. T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217972110 · Cited by 131

Atherosclerosis and the role of immune cells

İlhan, F. (2015) · World Journal of Clinical Cases · doi:10.12998/wjcc.v3.i4.345 · Cited by 127

On the Clinical Pharmacology of Reactive Oxygen Species

Casas, A. I., Nogales, C., Mucke, H. A., Petraina, A., Cuadrado, A., Rojo, A. I., Ghezzi, P., Jaquet, V., Augsburger, F., Dufrasne, F., et al. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019422 · Cited by 131

Celastrol in metabolic diseases: Progress and application prospects

Xu, S., Feng, Y., He, W., Xu, W., Xu, W., Yang, H., & Li, X. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105572 · Cited by 129

Plasma fibronectin deficiency impedes atherosclerosis progression and fibrous cap formation

Rohwedder, I., Montañez, E., Beckmann, K., Bengtsson, E., Dunér, P., Nilsson, J. Å., Soehnlein, O., & Fässler, R. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200237 · Cited by 128

Systems vaccinology: Enabling rational vaccine design with systems biological approaches

Hagan, T., Nakaya, H. I., Subramaniam, S., & Pulendran, B. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.03.072 · Cited by 131

MicroRNA: A new therapeutic strategy for cardiovascular diseases

Samanta, S., Balasubramanian, S., Rajasingh, S., Patel, U., Dhanasekaran, A., Dawn, B., & Rajasingh, J. (2016) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2016.02.004 · Cited by 128

T-Helper 2 Immunity Is Associated With Reduced Risk of Myocardial Infarction and Stroke

Engelbertsen, D., Andersson, L. I. M., Ljungcrantz, I., Wigren, M., Hedblad, B., Nilsson, J. Å., & Björkbacka, H. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300871 · Cited by 127

Unveiling the Role of the Most Impactful Cardiovascular Risk Locus through Haplotype Editing

Sardo, V. L., Chubukov, P., Ferguson, W. C., Kumar, A., Teng, E. L., Duran, M., Zhang, L., Cost, G. J., Engler, A. J., Urnov, F. D., et al. (2018) · Cell · doi:10.1016/j.cell.2018.11.014 · Cited by 122

Anti‐atherosclerotic effect of the angiotensin 1–7 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis

Skiba, D. S., Nosalski, R., Mikolajczyk, T. P., Siedliński, M., Rios, F. J. O., Montezano, A. C. I., Jawień, J., Olszanecki, R., Korbut, R., Cześnikiewicz‐Guzik, M., et al. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13685 · Cited by 127

Pharmacological activities and mechanisms of action of Pogostemon cablin Benth: a review

Junren, C., Xiaofang, X., Li, M.-T., Qiuyun, X., Li, G., Huiqiong, Z., Guanru, C., Xu, X., Yanpeng, Y., Peng, F., et al. (2021) · Chinese Medicine · doi:10.1186/s13020-020-00413-y · Cited by 134

An Endocrine Genetic Signal Between Blood Cells and Vascular Smooth Muscle Cells

Shan, Z., Qin, S., Li, W., Wu, W., Yang, J., Chu, M., Li, X., Huo, Y., Schaer, G. L., Wang, S., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.03.570 · Cited by 123

Epigenetic Control of Smooth Muscle Cell Identity and Lineage Memory

Gomez, D. A., Swiatlowska, P., & Owens, G. K. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.305044 · Cited by 131

Mitochondrial DNA-LL-37 Complex Promotes Atherosclerosis by Escaping from Autophagic Recognition

Zhang, Z., Meng, P., Han, Y., Shen, C., Li, B., Hakim, M. A., Zhang, X., Lu, Q., Rong, M., & Lai, R. (2015) · Immunity · doi:10.1016/j.immuni.2015.10.018 · Cited by 124

Vascular Cells in Blood Vessel Wall Development and Disease

Mazurek, R., Dave, J. M., Chandran, R. R., Misra, A., Sheikh, A. Q., & Greif, D. M. (2016) · Advances in pharmacology · doi:10.1016/bs.apha.2016.08.001 · Cited by 136

MicroRNA-210 Enhances Fibrous Cap Stability in Advanced Atherosclerotic Lesions

Eken, S. M., Jin, H. H., Chernogubova, E., Li, Y., Simon, N. L., Sun, C., Korzunowicz, G., Busch, A., Bäcklund, A., Österholm, C., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.309318 · Cited by 125

Mouse models of atherosclerosis and their suitability for the study of myocardial infarction

Golforoush, P. A., Yellon, D. M., & Davidson, S. M. (2020) · Basic Research in Cardiology · doi:10.1007/s00395-020-00829-5 · Cited by 135

Identification of bioactive compounds and potential mechanisms of scutellariae radix-coptidis rhizoma in the treatment of atherosclerosis by integrating network pharmacology and experimental validation

Ji, L., Song, T., Ge, C., Wu, Q.-L., Ma, L., Chen, X., Chen, T., Chen, Q., Chen, Z., & Chen, W. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115210 · Cited by 124

Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification

Kavousi, M., Bos, M. M., Barnes, H. J., Cardenas, C. L. L., Wong, D., Lu, H., Hodonsky, C. J., Landsmeer, L. P. L., Turner, A. W., Kho, M., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01518-4 · Cited by 124

Cellular immunity, low-density lipoprotein and atherosclerosis: Break of tolerance in the artery wall

Ketelhuth, D. F. J., & Hansson, G. K. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-05-0321 · Cited by 122

Blockade of NEAT1 represses inflammation response and lipid uptake via modulating miR‐342‐3p in human macrophages THP‐1 cells

Wang, L., Xia, J., Ke, Z., & Zhang, B. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27340 · Cited by 123

The critical roles of m6A modification in metabolic abnormality and cardiovascular diseases

Zhang, B., Jiang, H., Dong, Z., Sun, A., & Ge, J. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.07.011 · Cited by 125

The role of the gut microbiota in health and cardiovascular diseases

Wang, L., Wang, S., Zhang, Q., He, C., Fu, C., & Wei, Q. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00091-2 · Cited by 132

Modeling Supravalvular Aortic Stenosis Syndrome With Human Induced Pluripotent Stem Cells

Ge, X., Ren, Y., Bártulos, Ó., Lee, M. Y., Yue, Z., Kim, K., Li, W., Amos, P. J., Çağavi, E., Iyer, A., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.116996 · Cited by 124

High-Sensitivity C-Reactive Protein and Cardiovascular Disease Across Countries and Ethnicities

Fonseca, F. A. H., & Izar, M. C. D. O. (2016) · Clinics · doi:10.6061/clinics/2016(04)11 · Cited by 123

Atheroprotective Effects and Molecular Targets of Tanshinones Derived From Herbal Medicine Danshen

Fang, J., Little, P. J., & Xu, S. (2017) · Medicinal Research Reviews · doi:10.1002/med.21438 · Cited by 122

Radical Scavenging and Anti-Inflammatory Activities of Representative Anthocyanin Groupings from Pigment-Rich Fruits and Vegetables

Blando, F., Calabriso, N., Berland, H., Maiorano, G., Gerardi, C., Carluccio, M. A., & Andersen, Ø. M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010169 · Cited by 122

Sympathetic Neuronal Activation Triggers Myeloid Progenitor Proliferation and Differentiation

Vasamsetti, S. B., Florentin, J., Coppin, E., Stiekema, L. C. A., Zheng, K. H., Nisar, M. U., Sembrat, J., Levinthal, D. J., Rojas, M. M., Stroes, E. S. G., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.05.004 · Cited by 124

TGFβ, smooth muscle cells and coronary artery disease: a review

Low, E. L., Baker, A. H., & Bradshaw, A. C. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.09.004 · Cited by 127

The role of bone morphogenetic protein signaling in vascular calcification

Yang, P. B., Troncone, L., Augur, Z. M., Kim, S. S., McNeil, M. E., & Yu, P. B. (2020) · Bone · doi:10.1016/j.bone.2020.115542 · Cited by 127

Oral butyrate reduces oxidative stress in atherosclerotic lesion sites by a mechanism involving NADPH oxidase down-regulation in endothelial cells

Aguilar, E. C., dos Santos, L. C., Leonel, A. J., de Oliveira, J. S., dos Santos, E. A., Pelaez, J. M. N., da Silva, J. F., Mendes, B. P., Capettini, L. D. S. A., Teixeira, L. G., et al. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.05.002 · Cited by 120

Regulation of lipid metabolism by p53 – fighting two villains with one sword

Goldstein, I., & Rotter, V. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.06.007 · Cited by 124

Aspirin‐triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E−/− mice

Petri, M. H., Laguna‐Fernandez, A., Arnardottir, H., Wheelock, C. E., Perretti, M., Hansson, G. K., & Bäck, M. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13707 · Cited by 120

Genetics of atherosclerosis

Lusis, A. J. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.03.001 · Cited by 124

Advances in pig models of human diseases

Hou, N., Du, X., & Wu, S. (2022) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12223 · Cited by 127

Dysregulation of Histone Acetyltransferases and Deacetylases in Cardiovascular Diseases

Wang, Y., Miao, X., Liu, Y., Li, F., Liu, Q., Sun, J., & Cai, L. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/641979 · Cited by 119

Role of oxidative stress in carbon nanotube-generated health effects

Möller, P., Christophersen, D. V., Jensen, D. M., Kermanizadeh, A., Roursgaard, M., Jacobsen, N. R., Hemmingsen, J. G., Danielsen, P. H., Cao, Y., Jantzen, K., et al. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1356-x · Cited by 118

Plasmacytoid Dendritic Cells Play a Key Role in Promoting Atherosclerosis in Apolipoprotein E–Deficient Mice

MacRitchie, N. A., Grassia, G., Sabir, S. R., Maddaluno, M., Welsh, P. I., Sattar, N. A., Ialenti, A., Kurowska‐Stolarska, M., McInnes, I. B., Brewer, J. M., et al. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.251314 · Cited by 125

Lipids and lipid management in diabetes

Jaiswal, M., Schinske, A., & Pop‐Busui, R. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.12.001 · Cited by 118

Pathological overproduction: the bad side of adenosine

Borea, P. A., Gessi, S., Merighi, S., Vincenzi, F., & Varani, K. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13763 · Cited by 118

Perceived discrimination and cardiovascular health disparities: a multisystem review and health neuroscience perspective

Lockwood, K. G., Marsland, A. L., Matthews, K. A., & Gianaros, P. J. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13939 · Cited by 119

From Atherosclerotic Plaque to Myocardial Infarction—The Leading Cause of Coronary Artery Occlusion

Młynarska, E., Czarnik, W., Fularski, P., Hajdys, J., Majchrowicz, G., Stabrawa, M., Rysz, J., & Franczyk, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137295 · Cited by 143

Lipid-lowering therapy with statins reduces microparticle shedding from endothelium, platelets and inflammatory cells

Suades, R., Padró, T., Rodrigo Alonso, K., Mata, P., & Badimón, L. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-03-0238 · Cited by 115

The renin–angiotensin system and its involvement in vascular disease

van Thiel, B. S., van der Pluijm, I., Riet, L. T., Essers, J., & Danser, A. H. J. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.090 · Cited by 120

Benefits of Exercise Training on Coronary Blood Flow in Coronary Artery Disease Patients

Bruning, R. S., & Sturek, M. S. (2014) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2014.10.006 · Cited by 114

Gene Expression Signatures of Coronary Heart Disease

Joehanes, R., Ying, S., Huan, T., Johnson, A. D., Raghavachari, N., Wang, R., Liu, P., Woodhouse, K. A., Sen, S. K., Tanrıverdi, K., et al. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.301169 · Cited by 115

SIRT6 protects against endothelial dysfunction and atherosclerosis in mice

Xu, S., Yin, M., Koroleva, M., Mastrangelo, M. A., Zhang, W., Bai, P., Little, P. J., & Jin, Z. G. (2016) · Aging · doi:10.18632/aging.100975 · Cited by 113

The Dynamic Inflammatory Tissue Microenvironment: Signality and Disease Therapy by Biomaterials

Mata, R., Yao, Y., Cao, W., Ding, J., Zhou, T., Zhai, Z., & Gao, C. (2021) · Research · doi:10.34133/2021/4189516 · Cited by 116

Cholesterol in platelet biogenesis and activation

Wang, N., & Tall, A. R. (2016) · Blood · doi:10.1182/blood-2016-01-631259 · Cited by 114

Protective effects of mitochondria‐targeted antioxidants and statins on cholesterolinduced osteoarthritis

Farnaghi, S., Prasadam, I., Cai, G., Friis, T., Du, Z., Crawford, R., Mao, X., & Xiao, Y. (2017) · The FASEB Journal · doi:10.1096/fj.201600600r · Cited by 112

In Vivo Targeting and Imaging of Atherosclerosis Using Multifunctional Virus-Like Particles of Simian Virus 40

Sun, X., Li, W., Zhang, X., Qi, M., Zhang, Z., Zhang, X., & Cui, Z. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b02386 · Cited by 112

Effect of Circular ANRIL on the Inflammatory Response of Vascular Endothelial Cells in a Rat Model of Coronary Atherosclerosis

Song, C., Wang, J., Xue, X., Liu, N., Zhang, X., Zhao, Z., Liu, J.-G., Zhang, C., Piao, Z.-H., Liu, Y., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000478918 · Cited by 112

Revealing new landscape of cardiovascular disease through circular RNA-miRNA-mRNA axis

Su, Q., & Lv, X. (2019) · Genomics · doi:10.1016/j.ygeno.2019.10.006 · Cited by 114

HDL and ApoA-I inhibit antigen presentation-mediated T cell activation by disrupting lipid rafts in antigen presenting cells

Wang, S.-H., Yuan, S.-G., Peng, D.-Q., & Zhao, S.-P. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.07.029 · Cited by 111

Berberine treatment reduces atherosclerosis by mediating gut microbiota in apoE-/- mice

Shi, Y., Hu, J., Geng, J., Hu, T., Wang, B., Yan, W., Jiang, Y., Li, J., & Liu, S. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.148 · Cited by 111

Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosis

Hettwer, J., Hinterdobler, J., Miritsch, B., Deutsch, M.-A., Li, X., Mauersberger, C., Moggio, A., Braster, Q., Gram, H., Robertson, A. A. B., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab337 · Cited by 119

The complement system and toll-like receptors as integrated players in the pathophysiology of atherosclerosis

Hovland, A., Jonasson, L., Garred, P., Yndestad, A., Aukrust, P., Lappegård, K. T., Espevik, T., & Mollnes, T. E. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.05.038 · Cited by 113

Naringenin and Atherosclerosis: A Review of Literature

Orhan, İ. E., Nabavi, S. F., Daglia, M., Tenore, G. C., Mansouri, K., & Nabavi, S. F. (2015) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201015666141202110216 · Cited by 109

Yin-xing-tong-mai decoction attenuates atherosclerosis via activating PPARγ-LXRα-ABCA1/ABCG1 pathway

Zheng, S., Huang, H., Li, Y., Wang, Y., Zheng, Y., Liang, J., Zhang, S., Liu, M., & Fang, Z. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105639 · Cited by 115

Inflammation-related gene expression by lipid oxidation-derived products in the progression of atherosclerosis

Leonarduzzi, G., Gamba, P., Gargiulo, S., Biasi, F., & Poli, G. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.09.031 · Cited by 113

Nanotoxicity Overview: Nano-Threat to Susceptible Populations

Li, Y., Zhang, Y. L., & Yan, B. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15033671 · Cited by 111

Mechanoresponsive Networks Controlling Vascular Inflammation

Bryan, M. T., Duckles, H., Feng, S., Hsiao, S. T.-F., Kim, H. R., Serbanovic‐Canic, J., & Evans, P. C. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303424 · Cited by 109

Phenotypic switching of vascular smooth muscle cells in the ‘normal region’ of aorta from atherosclerosis patients is regulated by miR‐145

Zhang, Y., Xie, B., Sun, L., Chen, W., Jiang, S., Liu, W., Bian, F., Tian, H., & Li, R. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12825 · Cited by 111

Fine particulate matter air pollution and atherosclerosis: Mechanistic insights

Bai, Y., & Sun, Q. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.04.030 · Cited by 110

Effects of Olive Oil Phenolic Compounds on Inflammation in the Prevention and Treatment of Coronary Artery Disease

de Souza, P. A. L., Marcadenti, A., & Portal, V. L. (2017) · Nutrients · doi:10.3390/nu9101087 · Cited by 116

Immune system-mediated atherosclerosis caused by deficiency of long non-coding RNAMALAT1in ApoE−/−mice

Gast, M., Rauch, B. H., Nakagawa, S., Haghikia, A., Jasina, A., Haas, J., Nath, N., Jensen, L., Stroux, A., Böhm, A., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy202 · Cited by 114

High-density lipoproteins as modulators of endothelial cell functions: alterations in patients with coronary artery disease

Kratzer, A., Giral, H., & Landmesser, U. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu139 · Cited by 112

Potential therapeutic effects of mTOR inhibition in atherosclerosis

Kurdi, A., Meyer, G. R. Y. D., & Martinet, W. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12820 · Cited by 111

Chronic Low-grade Inflammatory Phenotype (CLIP) and Senescent Immune Dysregulation

Chen, Y., Liu, S., & Leng, S. X. (2019) · Clinical Therapeutics · doi:10.1016/j.clinthera.2019.02.001 · Cited by 108

The role of hepcidin and iron homeostasis in atherosclerosis

Wunderer, F., Traeger, L., Sigurslid, H. H., Meybohm, P., Bloch, D. B., & Malhotra, R. K. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104664 · Cited by 109

Coronary Artery Disease Genetics Enlightened by Genome-Wide Association Studies

Kessler, T., & Schunkert, H. (2021) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2021.04.001 · Cited by 111

Prognostic Utility of Neutrophil Gelatinase-Associated Lipocalin in Predicting Mortality and Cardiovascular Events in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention

Lindberg, S. Ø., Pedersen, S. H., Møgelvang, R., Jensen, J. S., Flyvbjerg, A., Galatius, S., & Magnusson, N. E. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.04.017 · Cited by 107

The Potential Therapeutic Application of Peptides and Peptidomimetics in Cardiovascular Disease

Recio, C., Μaione, F., Iqbal, A. J., Mascolo, N., & Feo, V. D. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00526 · Cited by 109

Quinic acid inhibits vascular inflammation in TNF-α-stimulated vascular smooth muscle cells

Jang, S., Park, D. W., Kwon, J. E., Song, H. S., Park, B., Jeon, H., Sohn, E., Koo, H. J., & Kang, S. C. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.10.021 · Cited by 110

Low-Density Lipoprotein Modified by Myeloperoxidase in Inflammatory Pathways and Clinical Studies

Delporte, C., Antwerpen, P. V., Vanhamme, L., Roumeguère, T., & Boudjeltia, K. Z. (2013) · Mediators of Inflammation · doi:10.1155/2013/971579 · Cited by 109

Thrombin generation and atherosclerosis

Kalz, J., Cate, H. T., & Spronk, H. M. H. (2013) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-013-1026-5 · Cited by 107

Toll-Like Receptor 7 Protects From Atherosclerosis by Constraining “Inflammatory” Macrophage Activation

Salagianni, M. L., Galani, I. E., Lundberg, A. M., Davos, C. H., Varela, A., Gavriil, A., Lyytikäinen, L., Lehtimäki, T. J., Sigala, F., Folkersen, L., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.067678 · Cited by 105

Ergothioneine as a Natural Antioxidant Against Oxidative Stress-Related Diseases

Fu, T.-T., & Shen, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.850813 · Cited by 106

Molecular Promiscuity of Plant Polyphenols in the Management of Age-Related Diseases: Far Beyond Their Antioxidant Properties

Barrajón‐Catalán, E., Herranz‐López, M., Joven, J., Segura‐Carretero, A., Alonso‐Villaverde, C., Menéndez, J. A., & Micol, V. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-07320-0_11 · Cited by 106

Nonpharmacological Lipoprotein Apheresis Reduces Arterial Inflammation in Familial Hypercholesterolemia

van Wijk, D. F., Sjouke, B., Figueroa, A. L., Emami, H., van der Valk, F. M., MacNabb, M. H., Hemphill, L., Schulte, D. M., Koopman, M. G., Lobatto, M. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.088 · Cited by 105

A Change in Inflammatory Footprint Precedes Plaque Instability: A Systematic Evaluation of Cellular Aspects of the Adaptive Immune Response in Human Atherosclerosis

van Dijk, R. A., Duinisveld, A. J. F., Schaapherder, A. F., Mulder-Stapel, A. A., Hamming, J. F., Kuiper, J., de Boer, O. J., van der Wal, A. C., Kolodgie, F. D., Virmani, R., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.114.001403 · Cited by 105

Known and potential health benefits and mechanisms of blueberry anthocyanins: A review

Wu, Y., Han, T., Yang, H., Lyu, L., Li, W., & Li, W. (2023) · Food Bioscience · doi:10.1016/j.fbio.2023.103050 · Cited by 113

Immune Activation and Inflammation in Patients with Cardiovascular Disease Are Associated with Higher Phenylalanine to Tyrosine Ratios: The Ludwigshafen Risk and Cardiovascular Health Study

Murr, C., Grammer, T. B., Meinitzer, A., Kleber, M. E., März, W., & Fuchs, D. (2014) · Journal of Amino Acids · doi:10.1155/2014/783730 · Cited by 104

Omega‐3 fatty acids, cardiovascular risk, and the resolution of inflammation

Bäck, M., & Hansson, G. K. (2019) · The FASEB Journal · doi:10.1096/fj.201802445r · Cited by 112

MicroRNAs in cardiovascular disease

Siasos, G., Bletsa, E., Stampouloglou, P. K., Oikonomou, E. K., Tsigkou, V., Paschou, S. Α., Vlasis, K. G., Marinos, G., Vavuranakis, M., Stefanadis, C., et al. (2020) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2020.03.003 · Cited by 104

Recommendations by the Asian Pacific society of nephrology ( APSN ) on the appropriate use of HIF‐PH inhibitors

Yap, D. Y. H., McMahon, L. P., Hao, C., Hu, N., Okada, H., Suzuki, Y., Kim, S. G., Lim, S. K., Vareesangthip, K., Hung, C., et al. (2020) · Nephrology · doi:10.1111/nep.13835 · Cited by 106

Management of oxidative stress and inflammation in cardiovascular diseases: mechanisms and challenges

Donia, T., & Khamis, A. A. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-14109-9 · Cited by 115

Reactive oxygen species scavenging and inflammation mitigation enabled by biomimetic prussian blue analogues boycott atherosclerosis

Zhang, Y., Yin, Y., Zhang, W., Li, H., Wang, T., Yin, H., Sun, L., Su, C., Zhang, K., & Xu, H. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00897-2 · Cited by 104

Interleukin-35 Inhibits Endothelial Cell Activation by Suppressing MAPK-AP-1 Pathway

Sha, X., Meng, S., Li, X., Xi, H., Maddaloni, M., Pascual, D. W., Shan, H., Jiang, X., Wang, H., & Yang, X. F. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.663286 · Cited by 104

Interleukin 23 Levels Are Increased in Carotid Atherosclerosis

Abbas, A., Gregersen, I., Holm, S., Daissormont, I., Bjerkeli, V., Krohg‐Sørensen, K., Skagen, K. R., Dahl, T. B., Russell, D., Almås, T., et al. (2015) · Stroke · doi:10.1161/strokeaha.114.006516 · Cited by 103

Insulin-like Growth Factor-1 Increases Synthesis of Collagen Type I via Induction of the mRNA-binding Protein LARP6 Expression and Binding to the 5′ Stem-loop of COL1a1 and COL1a2 mRNA

Blackstock, C. D., Higashi, Y., Sukhanov, S., Shai, S., Stefanovic, B., Tabony, A. M., Yoshida, T., & Delafontaine, P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.518951 · Cited by 103

LRP1 integrates murine macrophage cholesterol homeostasis and inflammatory responses in atherosclerosis

Xian, X., Ding, Y., Dieckmann, M., Zhou, L., Plattner, F., Liu, M., Parks, J. S., Hammer, R. E., Boucher, P., Tsai, S. X., et al. (2017) · eLife · doi:10.7554/elife.29292 · Cited by 102

Glycosides from Buyang Huanwu Decoction inhibit atherosclerotic inflammation via JAK/STAT signaling pathway

Fu, X., Sun, Z., Long, Q., Tan, W., Ding, H., Liu, X., Wu, L., Wang, Y., & Zhang, W. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154385 · Cited by 103

Translational atherosclerosis research: From experimental models to coronary artery disease in humans

Gleissner, C. A. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.03.013 · Cited by 21

Preparation Advances in Animal Models of Atherosclerosis

Mei-fan, L. (2013) · Medical Recapitulate

Immunity and Inflammation in Atherosclerosis

Wolf, D., & Ley, K. F. (2019) · Circulation Research · doi:10.1161/circresaha.118.313591 · Cited by 1,798

Experimental and human atherosclerosis: possible relationship and present status.

Bruger, M., & Oppenheim, E. (1951) · PubMed Central · Cited by 6

Animal Models of Atherosclerosis

Fuster, J. J., Castillo, A. I., Zaragoza, C., Ibáñez, B., & Andrés, V. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394596-9.00001-9 · Cited by 75